PF-Atlas › Clinical Trials › NCT02230982

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

nintedanib · Not specified

Registry ID
NCT02230982
Phase
Not specified
Status
No Longer Available
Drug / intervention
nintedanib
Sponsor
Boehringer Ingelheim
Locations
8

About this trial

To provide early access and to evaluate the safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF)

View NCT02230982 on ClinicalTrials.gov →

Explore related

All nintedanib trialsAll IPF trials

Related trials

nintedanib — NCT02606877Nintedanib — NCT02598193Nintedanib — NCT02579603Nintedanib — NCT02597933Nintedanib — NCT02999178Nintedanib — NCT02607722
Medical disclaimer. This page summarizes public trial data for NCT02230982 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.